Research map: Multi-site tumor sampling highlights molecular intra-tumor heterogeneity in malignant pleural mesothelioma

Back to the article

Papers in this map

  1. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 · Michael I. Love · 2014 · 104531 citations · Cited by this paper
  2. The 2021 WHO Classification of Tumors of the Pleura: Advances Since the 2015 Classification · Jennifer L. Sauter · 2022 · 203 citations · Cites this paper
  3. Transcriptome signatures for the identification of bevacizumab responders in ovarian cancer · 2026 · Related
  4. HTSeq—a Python framework to work with high-throughput sequencing data · Simon Anders · 2014 · 23287 citations · Cited by this paper
  5. Genomic landscape of pleural and peritoneal mesothelioma tumours · Stefanie Hiltbrunner · 2022 · 114 citations · Cites this paper
  6. Circulating tumor DNA precision oncology enables effective and sensitive molecular diagnostics and actionable target detection in pediatric solid tumors - the INFORM experience · 2026 · Related
  7. GSVA: gene set variation analysis for microarray and RNA-Seq data · Sonja Hänzelmann · 2013 · 17099 citations · Cited by this paper
  8. Tumour-wide RNA splicing aberrations generate actionable public neoantigens · Darwin W. Kwok · 2025 · 81 citations · Cites this paper
  9. Integrative stratification of response to immunotherapy using host and microbial signatures in patients with advanced non-small cell lung cancer · 2026 · Related
  10. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions · Daehwan Kim · 2013 · 13867 citations · Cited by this paper
  11. Guidelines for Pathologic Diagnosis of Mesothelioma: 2023 Update of the Consensus Statement From the International Mesothelioma Interest Group · Aliya Noor Husain · 2024 · 68 citations · Cites this paper
  12. Cell type-specific contextualisation of the human phenome: towards the systematic treatment of all rare diseases · 2026 · Related
  13. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples · Kristian Cibulskis · 2013 · 5466 citations · Cited by this paper
  14. Clinical and molecular validation of BAP1, MTAP, P53, and Merlin immunohistochemistry in diagnosis of pleural mesothelioma · David B. Chapel · 2022 · 62 citations · Cites this paper
  15. Long-read transcriptome sequencing and Drosophila-based functional validation reveal novel gene fusions in fusion panel-negative gliomas · 2026 · Related
  16. Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression · Étienne Becht · 2016 · 4135 citations · Cited by this paper
  17. NF2 alteration in mesothelioma · Yoshitaka Sekido · 2023 · 35 citations · Cites this paper
  18. Comprehensive genomic characterization of extraintestinal pathogenic Escherichia coli isolated from neonates: multiple center insights into virulence, resistance, and transmission dynamics · 2026 · Related
  19. WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs · Yuxing Liao · 2019 · 3542 citations · Cited by this paper
  20. NF2: An underestimated player in cancer metabolic reprogramming and tumor immunity · Duo Xu · 2024 · 32 citations · Cites this paper
  21. Infiltrating monocyte-derived macrophages does not survive long term in stroke brain despite their dominance in the acute ischemic core and myeloid derived IGF-1 play dichotomous roles in stroke recovery · 2026 · Related
  22. FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing · Ronglai Shen · 2016 · 1350 citations · Cited by this paper
  23. Pleural mesothelioma · Dean Anthony Fennell · 2025 · 27 citations · Cites this paper
  24. Advances in diagnosis and management of pleural mesothelioma: the Danish clinical guidelines · 2025 · Related
  25. Untitled · Cited by this paper
  26. Relationship between clonal evolution and drug resistance in bladder cancer: A genomic research review · Zhouting Tuo · 2024 · 24 citations · Cites this paper
  27. Multi-sampling allows intra-tumoral heterogeneity querying and vulnerability profiling in glioblastoma · 2026 · Related
  28. Untitled · Cited by this paper
  29. Optimal cancer evasion in a dynamic immune microenvironment generates diverse post-escape tumor antigenicity profiles · Jason Thomas George · 2023 · 20 citations · Cites this paper
  30. Untitled · Cited by this paper
  31. Diffuse Pleural Mesothelioma: Advances in Molecular Pathogenesis, Diagnosis, and Treatment · Christopher A. Febres‐Aldana · 2023 · 18 citations · Cites this paper
  32. Untitled · Cited by this paper
  33. Molecular and Immunohistochemical Testing in Mesothelioma and Other Mesothelial Lesions · Yin Pun Hung · 2024 · 17 citations · Cites this paper
  34. Untitled · Cited by this paper
  35. Current Management and Future Perspective in Pleural Mesothelioma · Rajiv C. Shah · 2022 · 14 citations · Cites this paper
  36. Untitled · Cited by this paper
  37. Establishing mesothelioma patient-derived organoid models from malignant pleural effusions · Ashleigh Jean Hocking · 2024 · 14 citations · Cites this paper
  38. Untitled · Cited by this paper
  39. Immunotherapy for mesothelioma: Moving beyond single immune check point inhibition · Luca Cantini · 2022 · 13 citations · Cites this paper

Source: OpenAlex (CC0)